Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07142239 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 2 of 2 changed
Primary endpoint added 1 → 2 primary endpoints
See other at-risk trials from New Valley University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified
    • Primary endpoint(s) modified
    • Recruitment opened
    • Secondary endpoints revised (2)
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary endpoints: 1 to 2
    • Study sites: 0 to 1
    • Secondary endpoints expanded, about 28 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Antiphospholipid syndrome is a thrombo-inflammatory autoimmune disorder with a complex antiphospholipid antibody-mediated pathogenesis, and high heterogeneity in clinical presentation and disease course. Clinical presentation in antiphospholipid syndrome includes venous and arterial thrombosis, pregnancy complications, and a broad range of microvascular and non-thrombotic manifestations
Trial Details
NCT Number NCT07142239
Lead Sponsor New Valley University
Conditions
(from sponsor)		 Antiphospholipid Syndrome
Related terms Antiphospholipid Syndrome
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov